- Home
- MRVI vs WNC Comparison
MRVI vs WNC Comparison
Compare MRVI & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- WNC
- Stock Information
- Founded
- MRVI 2014
- WNC 1985
- Country
- MRVI United States
- WNC United States
- Employees
- MRVI N/A
- WNC N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- WNC Construction/Ag Equipment/Trucks
- Sector
- MRVI Health Care
- WNC Industrials
- Exchange
- MRVI Nasdaq
- WNC Nasdaq
- Market Cap
- MRVI 376.2M
- WNC 396.7M
- IPO Year
- MRVI 2020
- WNC 1991
- Fundamental
- Price
- MRVI $3.14
- WNC $8.02
- Analyst Decision
- MRVI Hold
- WNC Hold
- Analyst Count
- MRVI 9
- WNC 1
- Target Price
- MRVI $4.54
- WNC $9.00
- AVG Volume (30 Days)
- MRVI 1.7M
- WNC 478.3K
- Earning Date
- MRVI 11-06-2025
- WNC 10-30-2025
- Dividend Yield
- MRVI N/A
- WNC 3.99%
- EPS Growth
- MRVI N/A
- WNC N/A
- EPS
- MRVI N/A
- WNC 6.15
- Revenue
- MRVI $219,830,000.00
- WNC $1,638,115,000.00
- Revenue This Year
- MRVI N/A
- WNC N/A
- Revenue Next Year
- MRVI $7.27
- WNC $17.22
- P/E Ratio
- MRVI N/A
- WNC $1.30
- Revenue Growth
- MRVI N/A
- WNC N/A
- 52 Week Low
- MRVI $1.67
- WNC $6.78
- 52 Week High
- MRVI $8.29
- WNC $20.63
- Technical
- Relative Strength Index (RSI)
- MRVI 48.93
- WNC 28.97
- Support Level
- MRVI $3.01
- WNC $8.75
- Resistance Level
- MRVI $3.55
- WNC $9.10
- Average True Range (ATR)
- MRVI 0.19
- WNC 0.37
- MACD
- MRVI -0.06
- WNC -0.04
- Stochastic Oscillator
- MRVI 20.31
- WNC 16.97
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.